CALCITRIOL RM calcitriol 0.25 microgram capsule blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

calcitriol, Quantity: 0.25 microgram

Commercializzato da:

Amneal Pharma Australia Pty Ltd

INN (Nome Internazionale):

Calcitriol

Forma farmaceutica:

Capsule, soft

Composizione:

Excipient Ingredients: fractionated coconut oil; butylated hydroxyanisole; butylated hydroxytoluene; Gelatin; glycerol; sorbitol solution (70 per cent) (non-crystallising); purified water; iron oxide red; iron oxide yellow; titanium dioxide

Via di somministrazione:

Oral

Confezione:

100 capsules

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Calcitriol RM is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of atraumatic fracture.,Calcitriol RM is also indicated for the prevention of corticosteroid-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss.,Calcitriol RM is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphataemic rickets.

Dettagli prodotto:

Visual Identification: Red coloured, oval soft gelatin capsules containing a clear oily liquid.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2015-12-01